Funding, Authority Questions Hinder Coverage With Evidence Development
Executive Summary
The Medicare Payment Advisory Commission is exploring whether CMS needs help in fostering its coverage with evidence development program, particularly in addressing its statutory authority to engage in CED and funding to maintain it
You may also be interested in...
CMS Sets The Stage For New Medicare "Coverage With Evidence Development" Guidance
A rarely-used tool for gathering data on medical technologies will get a fresh look as the agency solicits public comment on how to make CED a more meaningful and effective part of its coverage decision-making process.
Provenge Coverage With Data Collection Suggested By MEDCAC Members
The Centers for Medicare and Medicaid Services got a number of suggestions about linking Medicare coverage with data collection for Dendreon’s therapeutic prostate cancer vaccine Provenge at the Medicare Evidence Development and Coverage Advisory Committee’s Nov. 17 meeting.
Provenge Coverage With Data Collection Suggested By MEDCAC Members
The Centers for Medicare and Medicaid Services got a number of suggestions about linking Medicare coverage with data collection for Dendreon’s therapeutic prostate cancer vaccine Provenge at the Medicare Evidence Development and Coverage Advisory Committee’s Nov. 17 meeting.